Dare Bioscience (DARE)

• Market cap: $18.3M
• 1 day: -1.61%
• 5 days: -4.69%
• 1 month: -42.18%
• 3 months: -46.49%
• 6 months: -30.68%
• Year to date: -37.44%
• 1 year: -49.17%
• 5 years: -93.65%
• 10 years: -99.65%
• Sector: Healthcare
• Industry: Biotechnology

About: Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Employees: 24